LigaChem Biosciences

LigaChem Biosciences is focused on developing innovative drugs for unmet medical needs.
Request Access

About LigaChem Biosciences

LigaChem Biosciences is a company. It operates as a Professional Services, and Licensing Model. LigaChem Biosciences offers products and services including ADC Platform and Small Molecule Drugs.

  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of LigaChem Biosciences

LigaChem Biosciences offers a comprehensive portfolio of products and services, including ADC Platform and Small Molecule Drugs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Next-generation antibody-drug conjugates are developed for cancer treatment.

Innovative small molecule therapies are created for oncology.

People of LigaChem Biosciences
Headcount 10-50
Employee Profiles 14
Employee Profiles
People
Young Lag Cho
Chief Development Officer
People
Yun Hee Park
이사급 연구위원
People
Yong Zu Kim
CEO & President
People
Sejin Park
Chief Financial Officer & Vice President

Unlock access to complete

Funding Insights of LigaChem Biosciences

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by LigaChem Biosciences

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - LigaChem Biosciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ligachem Biosciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of LigaChem Biosciences

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ligachem Biosciences

Frequently Asked Questions about LigaChem Biosciences

What does LigaChem Biosciences do?

LigaChem Biosciences is engaged in the research and development of innovative drugs, particularly in the fields of antibody-drug conjugates (ADC) and small molecule therapies. The company is dedicated to addressing unmet medical needs through next-generation cancer treatments and immune-oncology solutions. Partnerships with global entities are leveraged to accelerate drug development. Operations are centered in the biotechnology and pharmaceutical sectors with a commitment to sustainable leadership through ESG initiatives.

What products or services does LigaChem Biosciences offer?

LigaChem Biosciences offers ADC Platform and Small Molecule Drugs.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available